Terms: = Leukemia AND ER, estrogen receptor AND Treatment
365 results:
1. TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell leukemia Cell Line HMC-1.2.
Ahmed N; Preisinger C; Wilhelm T; Huber M
Cells; 2024 Apr; 13(9):. PubMed ID: 38727283
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic effects of electroacupuncture and bone marrow mesenchymal stem cell transplantation on rat intrauterine adhesion： an observation.
Wang ZX; Xia LJ; Liu JY; Cui CT; Cheng J; Shen J; Xia YB
Zhen Ci Yan Jiu; 2023 Dec; 48(12):1209-1217. PubMed ID: 38146243
[TBL] [Abstract] [Full Text] [Related]
3. Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid leukemia.
Fan R; Satilmis H; Vandewalle N; Verheye E; De Bruyne E; Menu E; De Beule N; De Becker A; Ates G; Massie A; Kerre T; Törngren M; Eriksson H; Vanderkerken K; Breckpot K; Maes K; De Veirman K
Blood Cancer J; 2023 Dec; 13(1):188. PubMed ID: 38110349
[TBL] [Abstract] [Full Text] [Related]
4. Reduced Proteolipid Protein 2 promotes endoplasmic reticulum stress-related apoptosis and increases drug sensitivity in acute myeloid leukemia.
Xie F; Qu J; Lin D; Feng K; Tan M; Liao H; Zeng L; Xiong Q; Huang J; Chen W
Mol Biol Rep; 2023 Dec; 51(1):10. PubMed ID: 38085372
[TBL] [Abstract] [Full Text] [Related]
5. Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Häselbarth L; Gamali S; Saul D; Krumbholz M; Böttcher-Loschinski R; Böttcher M; Zou D; Metzler M; Karow A; Mougiakakos D
BMC Cancer; 2023 Nov; 23(1):1153. PubMed ID: 38012567
[TBL] [Abstract] [Full Text] [Related]
6. EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer.
Xie Y; Han X; Yu J; Yuan M; Yan Y; Qin J; Lan L; Wang Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18103-18117. PubMed ID: 37999751
[TBL] [Abstract] [Full Text] [Related]
7. Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
Abadeh A; Shehadeh S; Betschel S; Waserman S; Cameron DW; Cowan J
PLoS One; 2023; 18(11):e0294408. PubMed ID: 37971974
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Chang YS; Gills JJ; Kawabata S; Onozawa M; Della Gatta G; Ferrando AA; Aplan PD; Dennis PA
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37800623
[TBL] [Abstract] [Full Text] [Related]
9. GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.
Gallo Cantafio ME; Torcasio R; Scionti F; Mesuraca M; Ronchetti D; Pistoni M; Bellizzi D; Passarino G; Morelli E; Neri A; Viglietto G; Amodio N
Cells; 2023 Sep; 12(18):. PubMed ID: 37759449
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
11. Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies.
Sun S; Qin J; Liao W; Gao X; Shang Z; Luo D; Xiong S
Cardiovasc Toxicol; 2023 Aug; 23(7-8):233-254. PubMed ID: 37479951
[TBL] [Abstract] [Full Text] [Related]
12. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-CHOP pathway.
Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
[TBL] [Abstract] [Full Text] [Related]
13. Aged black garlic extract inhibits the growth of estrogen receptor-positive breast cancer cells by downregulating MCL-1 expression through the ROS-JNK pathway.
Yang Q; Li F; Jia G; Liu R
PLoS One; 2023; 18(6):e0286454. PubMed ID: 37352173
[TBL] [Abstract] [Full Text] [Related]
14. Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells.
Shahrani MA; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y; Gahtani RM; Radhakrishnan S; Dagreery K
Oncol Res; 2021; 29(3):149-157. PubMed ID: 37304671
[TBL] [Abstract] [Full Text] [Related]
15. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Hoff FW; Qiu Y; Brown BD; Gerbing RB; Leonti AR; Ries RE; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Jenkins GN; Horton TM; Kornblau SM
Proteomics Clin Appl; 2023 Nov; 17(6):e2200109. PubMed ID: 37287368
[TBL] [Abstract] [Full Text] [Related]
16. Nanoemulsion-Based System as a Novel and Promising Approach for Enhancing the Antimicrobial and Antitumoral Activity of Thymus vulgaris (L.) Oil in Human Hepatocellular Carcinoma Cells.
Nasra S; Meghani N; Kumar A
Appl Biochem Biotechnol; 2024 Feb; 196(2):949-970. PubMed ID: 37273096
[TBL] [Abstract] [Full Text] [Related]
17. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
[TBL] [Abstract] [Full Text] [Related]
18. Melatonin Can Enhance the Effect of Drugs Used in the treatment of leukemia.
Lomovsky AI; Baburina YL; Fadeev RS; Lomovskaya YV; Kobyakova MI; Krestinin RR; Sotnikova LD; Krestinina OV
Biochemistry (Mosc); 2023 Jan; 88(1):73-85. PubMed ID: 37068876
[TBL] [Abstract] [Full Text] [Related]
19. Polypeptide antibiotic actinomycin D induces Mcl-1 uncanonical downregulation in lung cancer cell apoptosis.
Chen CL; Tseng PC; Chao YP; Shen TJ; Jhan MK; Wang YT; Nguyen TT; Lin CF
Life Sci; 2023 May; 321():121615. PubMed ID: 37001403
[TBL] [Abstract] [Full Text] [Related]
20. Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice.
Youssef ME; Cavalu S; Hasan AM; Yahya G; Abd-Eldayem MA; Saber S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902446
[TBL] [Abstract] [Full Text] [Related]
[Next]
